Notice: Function _load_textdomain_just_in_time was called incorrectly. Translation loading for the wordpress-seo domain was triggered too early. This is usually an indicator for some code in the plugin or theme running too early. Translations should be loaded at the init action or later. Please see Debugging in WordPress for more information. (This message was added in version 6.7.0.) in /var/www/html/wp-includes/functions.php on line 6260 Orbis, Daré Bioscience Enter License Agreement | Contract Pharma

What are you searching for?

Sign in
Breaking News, Collaborations & Alliances

Orbis, Daré Bioscience Enter License Agreement

Daré Bioscience can now license worldwide rights to Orbis' long-acting contraceptive products

By: Betsy Louda

, Contract Pharma

Orbis Biosciences has granted Daré Bioscience an exclusive option to license worldwide rights to Orbis’ long-acting contraceptive products.  This agreement leverages Orbis’ Stratµm™ technology to create an etonogestrel contraceptive for 6- and 12-month durations.  The agreement includes pre-clinical studies and the option to enter into a license agreement for clinical development.  Financial terms were not disclosed.

 

“Our long-acting contraceptive products were developed to fill a gap in the options currently available to women.  We are excited by Daré’s commitment to developing novel women’s health products,” said Maria Flynn, chief executive officer and president of Orbis Biosciences.

 

“Orbis’s products fit Daré’s commitment to advance innovative products for women’s reproductive health.  We are dedicated to finding the best products and cultivating them for the United States’ contraceptive and sexual-health needs,” said Sabrina Martucci Johnson, president and chief executive officer of Daré Bioscience. 

 

Add us as a preferred source on Google

Get the latest Contract Pharma news, insights and analysis in your Google Search and AI experiences.

Add Contract Pharma as a preferred source on Google (opens in a new tab)

Keep Up With Our Content. Subscribe To Contract Pharma Newsletters

Topics